Differentiation of osteoclasts is defined by the transcription factors expressed in response to bone microenvironments. In this work, we examined the effects of an expressional blockage of Egr-1 and/or WT1 on the differentiation of osteoclasts using specific antisense oligodeoxynucleotides (ODN). In a culture system forming preosteoclast-like cells (POC) from rat bone marrow cells depleted of marrow stromal cells, POC formation was markedly stimulated by the addition of Egr-1 antisense ODN compared to that in cultures in which sense ODN was added, whereas Egr-1 antisense ODN inhibited the formation of macrophage-like cells. The formation of multinucleated osteoclast-like cells was also stimulated by the addition of Egr-1 antisense ODN in whole bone marrow cultures. In contrast, WT1 antisense ODN did not affect POC formation induced by the treatment with Egr-1 antisense ODN; however, WT1 antisense ODN dramatically suppressed the formation of osteoclast-like multinucleated cells induced by the blockage of Egr-1 expression using Egr-1 antisense ODN. These data suggest that Egr-1 acts as the suppressor, not as the inducer, in osteoclastogenesis. The findings also suggested that WT1 could be involved in the multinucleation step of osteoclastogenesis, at least when Egr-1 expression was blocked. (Endocrinology 138: 4384 -4389, 1997) 
A TRANSCRIPTION factor designated the early growth response gene-1 (Egr-1) with three zinc-finger motifs is one of the EGR family that has zinc finger motifs at the C-terminal region of the protein. It was originally discovered as a growth response gene in cultured cells and in response to B cell maturation (1) . However, Nguyen et al. (2) demonstrated that the expression of Egr-1 is essential for the differentiation of macrophages; they reported a series of findings revealing that Egr-1 has a critical role in the differentiation of earlier progenitor cells to macrophages. Egr-1 binds the G-rich consensus sequence (5Ј-GCGGGGGCG-3Ј) of the control region of the target genes followed by activation of the target genes (3) (4) (5) . WT1, also a member of the EGR family, has four zinc finger motifs, and was discovered as a gene product of the tumor suppressor gene in Wilms' kidney tumors; it binds to the same consensus sequence as Egr-1 (6 -8) and acts as the transcriptional repressor against target genes, whereas Egr-1 acts as the transcriptional activator (9 -11) .
The cell lineage of the osteoclasts is considered to be very close to that of the macrophages (12) . It has been reported that mononuclear phagocytes can be differentiated into osteoclasts when these cells are cocultured with bone rudiments stripped off the osteum (13) . The formation of osteoclasts from alveolar macrophages has also been reported (14) . We recently found that a macrophage cell line, BDM-1, has an ability to differentiate into osteoclast-like cells (15) . Further experiments using the osteopetrotic op/op mice demonstrated that macrophage colony-stimulating factor (M-CSF) is an essential cytokine for osteoclastogenesis (16 -19) . Thus, it is widely accepted that colony-forming unit macrophages are the most probable candidates for the progenitor cells of the osteoclasts. As cells in the osteoclast lineage are closely related to the monocyte/macrophages, differentiation of osteoclasts may be regulated by transcription factors common to those in macrophages.
In the present study, we studied the possible regulatory roles of the zinc finger transcription factors Egr-1 and WT1 in osteoclastogenesis by creating an expressional blockage of these transcription factors by antisense oligodeoxynucleotides (ODNs) specific to each gene.
Materials and Methods Materials
Male Sprague-Dawley rats (4 -6 weeks old) were obtained from SEAC Yoshitomi (Fukuoka, Japan). Cytochemical staining kits for tartrate-resistant acid phosphatase (TRAP) and nonspecific esterase were purchased from Sigma Chemical Co. (St. Louis, MO). The ABC-AP kit was obtained from Vector Laboratories (Burlingame, CA). Unmodified or phosphorothioated ODNs of designed sequences were prepared and purified with HPLC by Takara Biomedicals (Kyoto, Japan).
with the cytochemical staining kit for TRAP or with the osteoclastspecific monoclonal antibody Kat1 (mAb Kat1) as described previously (20) . The presence of macrophages was also monitored by staining for nonspecific esterase.
Stromal cell-deprived bone marrow cultures for forming preosteoclasts. Bone marrow cells were deprived of stromal cells by use of a Sephadex G-10 column. Cells (4 ϫ 10 5 ; in 100 l ␣MEM containing 15% FCS) were seeded into 96-well culture plates, or 10 6 cells (in 500 l ␣MEM containing 15% FCS) were seeded into 24-well culture plates in the presence of 10% heat-treated conditioned medium with a molecular mass of more than 10 kDa (htROSCM) and 10 Ϫ8 m 1␣, 25- 
Design of antisense ODNs
Antisense ODN, sense ODN, and scrambled ODNs were designed and prepared based on the DNA sequence database (GenBank). The optimum sequence of 20 bases for generating specific ODNs was searched by analyzing the 5Ј-upstream regions of the open reading frames of each gene. In the case of Egr-1, the most specific regions for mouse Egr-1 (GenBank accession no. M20157) and rat Egr-1 (GenBank accession no. M18416) were selected, and these regions exactly correspond to the sequence of antisense ODN reported by Nguyen et al. (2) . Sequence 141-160 of mouse Egr-1 is identical to sequence 151-170 of rat Egr-1, and this portion was selected for generating the Egr-1 antisense ODN. Scrambled sequences (Scr 1 and Scr 2) with the same base ratio as either the sense ODN or the antisense ODN were confirmed to have no homology to any sequences reported to date in the GenBank DNA database. For the WT1 antisense ODN, two different portions of the sequence were selected after analyzing the 5Ј-upstream region of the second open reading frame of mouse WT1 (GenBank accession no. M55512) and the initial 300 bases of this open reading frame. Sequence 441-460 of mouse WT1 was selected because this region is highly specific to mouse WT1. Sequence 469 -488 of mouse WT1 was also selected. This region is highly specific to mouse WT1 and rat WT1. This sequence is identical to sequence 7-26 of rat WT1 (GenBank accession no. X69716). These two regions were used for generating the WT1 antisense ODNs. Scrambled sequences with the same base ratio as that of the WT1 antisense ODNs were designed for each portion. These scrambled sequences were confirmed to have no homology to any sequences reported in the GenBank DNA database.
Results

Induction of preosteoclast-like cells and osteoclast-like MNCs by treatment with Egr-1 antisense ODN
The 5Ј-upstream region of the Egr-1 open reading frame is highly conserved between mouse and rat. The mouse 141-160 sequence is completely conserved in rat 151-170, as shown in Fig. 1 . This mouse sequence was used by Nguyen et al. (2) to generate antisense ODNs that inhibit macrophage differentiation. We examined whether antisense Egr-1 affects the formation of osteoclast-like MNCs in whole bone marrow cultures induced with 1␣,25-(OH) 2 D 3 and htROSCM, specific inducers of osteoclast-like MNCs in rat bone marrow culture system (21, 22) . Egr-1 antisense ODN markedly stimulated the formation of TRAP-positive MNCs compared to that in controls in which Egr-1 sense or scrambled ODN was added to bone marrow cultures for forming osteoclast-like MNCs, as shown in Fig. 4 . We confirmed that osteoclast-like MNCs induced by the presence of Egr-1 antisense ODN have the ability to efficiently resorb dentin. We further confirmed that these MNCs expressed the calcitonin receptor and the Kat1 antigen, a specific cell surface marker for cells in the osteoclast lineage of rats (data not shown). These data show that treatment of bone marrow cultures with Egr-1 antisense ODN resulted in a marked increase in the number of cells of osteoclast lineage. These data strongly suggest the presence of another transcription factor that is required for osteoclastogenesis when Egr-1 expression is blocked by Egr-1 antisense ODN. (2) . They showed complete inhibition of macrophage formation using this antisense ODN (141-160 of mouse Egr-1; AS Egr-1). This region corresponds to sequence 151-170 of rat Egr-1. For control experiments, the sense ODN (SEgr-1) with a sequence complementary to that of antisense ODN and the scrambled ODN with the same base ratio as sense ODN (Scr 1 Egr-1) or as antisense ODN (Scr 2 Egr-1) were used. For the expressional blockage of WT1, the specific region of mouse WT1 was selected as described in Materials and Methods. Two portions (441-460 and 469 -488) were selected. The latter portion (mouse 469 -488) corresponds to sequence 7-26 of rat WT1. For control experiments, the sense ODN (S WT1), with a sequence complementary to that of antisense ODN, and the scrambled ODN (Scr WT1), with the same base ratio as antisense ODN, were prepared. ORF, Open reading frame.
Regulation of osteoclast-like MNC formation by Egr-1 antisense ODN and by WT1 antisense ODN
We next examined the possibility that WT1 is involved in the stimulation of osteoclastogenesis induced by treatment with Egr-1 antisense ODN. Antisense ODNs that specifically bind WT1 messenger RNA were designed, as shown in Fig.  1 . Two portions were selected for generating antisense ODNs. One is the 5Ј-region upstream from the initiation codon, and the other is the region including the initiation codon of the second open reading frame of the mouse WT1 gene. Antisense ODN, sense ODN, and scrambled ODN were prepared, and the effects of these ODNs on the formation of osteoclast-like MNC were examined. As shown in Fig. 7 . We further confirmed this using stromal cell-deprived bone marrow cells for forming POC. POC formation induced by the addition of AS Egr-1 ODN was not suppressed by the addition of AS WT1 ODN (Table 1 ). These data suggest that the POC formation step is not under the control of WT1 and that the formation of MNCs induced by the expressional blockage of Egr-1 was completely suppressed by the expressional blockage of WT1 without altering the formation of mononuclear precursors of the osteoclasts.
Discussion
It is quite true that osteoclasts and macrophages share many characteristics; these two cell lineages originate in common progenitor cells. We, therefore, examined whether osteoclast differentiation would be affected when macrophage differentiation was blocked by suppressing the expression of Egr-1, a zinc finger-type transcription factor able to differentiate early progenitor cells into macrophages. Our findings were contrary to our expectation that osteoclast differentiation would also be inhibited by the expressional blockage of Egr-1. The formation of mononuclear preosteoclast-like cells and multinucleated osteoclast-like MNCs was markedly stimulated by the addition of Egr-1 antisense ODN compared to sense control as well as scrambled control, as summarized in Fig. 8 . Our data strongly suggest that Egr-1 acts as a suppressor for osteoclastogenesis and that there are other transcription factors required for osteoclastogenesis, at least when Egr-1 expression is blocked. One candidate for the transcription factor with the ability to antagonize Egr-1 function is WT1, the product of the Wilms' tumor suppressor gene, which is a member of the EGR family with four C2H2-type zinc finger motifs (6 -11). As we demonstrated in this study, WT1 antisense ODN completely suppressed the formation of osteoclast-like MNCs induced by an expressional blockage of Egr-1 as summarized in Fig. 8 . Our data suggest that WT1 has some role in the multinucleation step in osteoclastogenesis when bone marrow cultures were treated with Egr-1 antisense ODN. WT1 is supposed to bind consensus sequence of Egr-1 in place of Egr-1 itself when the expression of Egr-1 is blocked, thereby this tumor suppressor gene product could express its unique biological activity in osteoclastogenesis. This multinucleation step is one of the most important steps in osteoclast differentiation; however, little is known about the molecular mechanism of this step. The expression of key molecules essential for the specific fusion process among osteoclast precursors may be under the control of WT1. Interestingly, the preosteoclast formation induced by Egr-1 antisense ODN in whole bone marrow cultures was not affected by the expressional blockage of WT1, suggesting that WT1 is not involved in regulation of the mononuclear precursor formation. There may be some other strong inducer of osteoclastogenesis in the formation of preosteoclasts from early progenitors.
Grigoriadis et al. (23) reported that c-fos, known as a transcription factor that binds the AP1 site after being heteromerized with the partner protein of the Jun family, is essential for osteoclastogenesis, as determined after detailed analysis of c-fos gene-deficient mice generated by the ho- mologous recombination of the c-fos allele in embryonic stem cells (24) . Homozygous mutants of the c-fos allele have an osteopetrotic phenotype due to a failure in normal osteoclast formation. The lack of c-fos caused a lineage shift between osteoclasts and macrophages resulting in the formation of increased numbers of bone marrow macrophages, suggesting that c-fos is essential for osteoclast differentiation, but not for macrophage differentiation. In our culture system, the reason why the formation of preosteoclasts induced by Egr-1 antisense ODN was not suppressed by WT1 antisense ODN may have been a high expression of c-fos in this step. Other osteopetrotic mutant mice (mi/mi) have been shown to have an abnormality in the helix-loop-helix-type transcription factor (25) . Mi/mi mice express an abnormality in mast cell differentiation as well as osteoclast differentiation. Their study (25) suggests an important role of the helix-loop-helixtype transcription factor in osteoclastogenesis. As is shown in the differentiation of other hematopoietic cells, there could be some hierarchy in the expression of transcription factors in the differentiation of osteoclasts. Further detailed analyses are required concerning the time-course expression of transcription factors involved in osteoclastogenesis in our in vitro culture system of osteoclast differentiation.
M-CSF has been shown to be an essential cytokine for osteoclast differentiation from a series of studies using osteopetrotic (op/op) mice. Harrington et al. (26) reported that the expression of M-CSF is induced by Egr-1 and suppressed by WT1. They further demonstrated binding of SP1 and SP3 to the consensus sequence of Egr-1 present at the upstream region of the M-CSF gene. To give a simple interpretation, the expressional blockage of Egr-1 would result in a reduced production of M-CSF, and that of WT1 would result in an increased production of M-CSF. As the M-CSF is an essential cytokine for osteoclastogenesis, a change in the level of M-CSF should affect the formation of osteoclast-like MNCs. Additional studies are required concerning the minute changes in the level of M-CSF in our culture system.
In the present study, we obtained findings suggesting the role of WT1 in the multinucleation step in osteoclastogenesis. With respect to the biological role of WT1, Kreidberg et al. (27) reported that this zinc finger transcription factor has a crucial role in early urogenital development. In their report, WT1-deficient mice die on embryonic day 15 because of the abnormality of kidney development. As these mutant animals die so early, the role of WT1 in skeletal tissue remains unknown. The WT1 gene has 10 exons that give rise to several protein isoforms through alternative splicing (28) . In our present study, WT1 antisense ODN was generated for the 5Ј-upstream region of the initiation codon and for a region around the initiation codon of the second open reading frame; thereby, the expression of every type of splicing variant can be affected by treatment with this antisense ODN. It will be interesting to determine which type of splicing variant is used in osteoclastogenesis.
In this study, we successfully demonstrated the clear effect of antisense ODNs on osteoclastogenesis in a rat bone marrow culture system. These in vitro studies can be expanded to in vivo studies. As the antisense ODN is not a stable reagent even as a phosphorothioated ODN, this aspect provides an opportunity for creating safer drugs that regulate bone metabolism by a specific blocking of osteoclast differentiation but do not affect the differentiation of macrophages, which play central roles in the immunological defense of the body. In vivo studies examining the direct regulation of osteoclastogenesis are underway in our laboratories.
